Protalix Biotherapeutics | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Protalix BioTherapeutics
FDA

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

pharmacompass-1-m-2026-01-12

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Together we can improve the quality of life

Contact Supplier

pharmacompass-2-m-2025-11-03

Protalix BioTherapeutics

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 104 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
104 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

1 All APIs, 1 NDC API

1 All APIs
1 NDC API

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

REF. STANDARDS & IMPURITIES

1 Others

1 Others

INSPECTIONS & REGISTRATIONS

4 FDA

4 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

4 All

01 1Protalix Biotherapeutics

02 3Protalix Ltd.

filter District Decision Reset all filters

4 All

01 2No Action Indicated

02 2Voluntary Action Indicated

filter Inspection End Date Reset all filters

4 All

01 12019-07-11

02 12015-05-14

03 12010-11-11

04 12010-10-17

filter City Reset all filters

4 All

01 3Karmi'El

02 1Karmiel

filter Country/Area Reset all filters

4 All

01 4Israel

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

IPPE

Not Confirmed

FDA Audited

USA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2019-07-11

Protalix BioTherapeutics

City : Karmi'El

State :

Country/Area : Israel

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2019-07-11

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

IPPE

Not Confirmed

FDA Audited

USA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2015-05-14

Protalix BioTherapeutics

City : Karmi'El

State :

Country/Area : Israel

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2015-05-14

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

IPPE

Not Confirmed

FDA Audited

USA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2010-11-11

Protalix BioTherapeutics

City : Karmiel

State :

Country/Area : Israel

Zip :

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2010-11-11

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

FDA Audited

USA

IPPE

Not Confirmed

FDA Audited

USA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-10-17

Protalix BioTherapeutics

City : Karmi'El

State :

Country/Area : Israel

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-10-17

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact Protalix Biotherapeutics and get a quotation

Protalix Biotherapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Taliglucerase Alfa bulk offered by Protalix Biotherapeutics

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.